Ozaki S - Search Results

1

Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.

Nakano A, Abe M, Oda A, Amou H, Hiasa M, Nakamura S, Miki H, Harada T, Fujii S, Kagawa K, Takeuchi K, Watanabe T, Ozaki S, Matsumoto T. Nakano A, et al. Among authors: ozaki s. Int J Hematol. 2011 Jun;93(6):727-735. doi: 10.1007/s12185-011-0850-7. Epub 2011 Apr 28. Int J Hematol. 2011. PMID: 21526377

2

[Advances in biology and pathogenesis of multiple myeloma].

Kosaka M, Abe M, Takishita M, Ozaki S, Goto T. Kosaka M, et al. Among authors: ozaki s. Nihon Rinsho. 1995 Mar;53(3):627-35. Nihon Rinsho. 1995. PMID: 7699896 Review. Japanese.

3

Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24.

Ozaki S, Kosaka M, Wakatsuki S, Abe M, Koishihara Y, Matsumoto T. Ozaki S, et al. Blood. 1997 Oct 15;90(8):3179-86. Blood. 1997. PMID: 9376601 Free article.

4

Multiple myeloma: new aspects of biology and treatment.

Ozaki S, Kosaka M. Ozaki S, et al. J Med Invest. 1998 Feb;44(3-4):127-36. J Med Invest. 1998. PMID: 9597800 Review.

5

Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection.

Ozaki S, Ogasahara K, Kosaka M, Inoshita T, Wakatsuki S, Uehara H, Matsumoto T. Ozaki S, et al. J Med Invest. 1998 Feb;44(3-4):215-7. J Med Invest. 1998. PMID: 9597812

6

Radioimmunodetection of human myeloma xenografts with a monoclonal antibody directed against a plasma cell specific antigen, HM1.24.

Ozaki S, Kosaka M, Harada M, Nishitani H, Odomi M, Matsumoto T. Ozaki S, et al. Cancer. 1998 Jun 1;82(11):2184-90. doi: 10.1002/(sici)1097-0142(19980601)82:11<2184::aid-cncr13>3.0.co;2-q. Cancer. 1998. PMID: 9610698

7

Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells.

Ozaki S, Kosaka M, Wakahara Y, Ozaki Y, Tsuchiya M, Koishihara Y, Goto T, Matsumoto T. Ozaki S, et al. Among authors: ozaki y. Blood. 1999 Jun 1;93(11):3922-30. Blood. 1999. PMID: 10339501 Free article.

8

Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia.

Tani R, Ozaki S, Kosaka M, Fujiwara S, Shibata H, Wakatsuki S, Matsumoto T. Tani R, et al. Among authors: ozaki s. Br J Haematol. 1999 Sep;106(3):709-12. doi: 10.1046/j.1365-2141.1999.01594.x. Br J Haematol. 1999. PMID: 10468861 Free article.

9

Solitary plasmacytoma with VEGF overproduction: report of a patient with polyneuropathy.

Nakano A, Mitsui T, Endo I, Takeda Y, Ozaki S, Matsumoto T. Nakano A, et al. Among authors: ozaki s. Neurology. 2001 Mar 27;56(6):818-9. doi: 10.1212/wnl.56.6.818. Neurology. 2001. PMID: 11274332 No abstract available.

10

Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma.

Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S, Wakatsuki S, Kosaka M, Kido S, Inoue D, Matsumoto T. Abe M, et al. Among authors: ozaki s. Blood. 2002 Sep 15;100(6):2195-202. Blood. 2002. PMID: 12200385 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,127 results

Search Page

Filters